Listed by the USPTO as SEREBOFF, NEAL
Tech Center 3600 • Art Units: 1685 3626 3683 3697
This examiner grants 28% of resolved cases
SEREBOFF, NEAL works in Tech Center 3600 and art unit 1685. The profile includes 513 resolved cases, a 28.3% allowance rate, and a 33.4% interview lift. The median days to allowance is 1741, indicating the longest observed timeline in this profile and a need for substantial prosecution planning.
The listed companies are BAXTER CORPORATION ENGLEWOOD, Datadose LLC, and Canon Inc. The listed firms are K&L Gates LLP-Chicago, Jordan IP Law, LLC, and OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P. The strong positive interview measure makes examiner discussions worth considering, but the low allowance rate means interviews should be paired with rigorous claim strategy and persistence.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19396551 | X-RAY CT APPARATUS, MEDICAL INFORMATION PROCESSING SYSTEM, AND MEDICAL INFORMATION PROCESSING METHOD | Non-Final OA | Canon Kabushiki Kaisha |
| 17214659 | SYSTEM AND METHOD FOR USE OF PATTERN DETECTION IN ASSESSING SELF-REPORTED SYMPTOM DATA | Final Rejection | ORACLE INTERNATIONAL CORPORATION |
| 18725394 | BADGE AND PATIENT SUPPORT APPARATUS COMMUNICATION SYSTEM | Non-Final OA | Stryker Corporation |
| 18200003 | HEALTH DATABASE UPDATING | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18242335 | PERSONALIZED RENAL FAILURE CHRONIC CARE SYSTEMS AND METHODS | Final Rejection | BAXTER HEALTHCARE SA |
| 18352390 | METHOD OF DIFFERENTIATING PATTERNS OF CARE | Non-Final OA | International Business Machines Corporation |
| 18978350 | MEDICAL RECORD DIGEST | Non-Final OA | ZOLL Medical Corporation |
| 18106107 | CENTRAL USER MANAGEMENT IN A DISTRIBUTED HEALTHCARE INFORMATION MANAGEMENT SYSTEM | Final Rejection | BAXTER CORPORATION ENGLEWOOD |
| 17965030 | MANAGEMENT OF MEDICATION PREPARATION WITH DYNAMIC PROCESSING | Non-Final OA | BAXTER CORPORATION ENGLEWOOD |
| 19170306 | METHODS AND SYSTEMS USING DEEP-LEARNING FOR IDENTIFYING PULMONARY VEIN ISOLATION NON-RESPONDERS | Final Rejection | Biosense Webster (Israel) Ltd. |
| 19223426 | Blood Purification System | Non-Final OA | Nikkiso Company Limited |
| 18757266 | NUTRITION AND DEPRESCRIPTION | Non-Final OA | CVS Pharmacy, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy28.3% of resolved applications examined by Neal Sereboff were allowed (513 resolved cases), compared with 40.5% across Art Unit 1685 over the last five years.
This examiner's interview lift is +33.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Neal Sereboff took 1,741 days on average from filing to allowance.
Neal Sereboff examines applications in Art Unit 1685 in Tech Center 3600 (Transportation, E-Commerce & Mechanical Systems).
